性猛交XXXX乱大交派对,四虎影视WWW在线观看免费 ,137最大但人文艺术摄影,联系附近成熟妇女

中文名稱

英文名稱

利格列汀標(biāo)準(zhǔn)品

Linagliptin

利格列汀雜質(zhì)1

2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide

利格列汀雜質(zhì)2

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質(zhì)3

N-Phthalimide-linagliptin

利格列汀雜質(zhì)4

N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide

利格列汀雜質(zhì)5

(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid

利格列汀雜質(zhì)6

8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)

利格列汀雜質(zhì)7

Linagliptin Diene Impurity

利格列汀雜質(zhì)8

Linagliptin Acetamide

利格列汀雜質(zhì)9

(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

利格列汀雜質(zhì)10

(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione

利格列汀雜質(zhì)11

8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質(zhì)12

(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

利格列汀雜質(zhì)13

(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質(zhì)14

(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質(zhì)15

(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide

利格列汀雜質(zhì)16

(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質(zhì)17

(S)-Linagliptin

利格列汀雜質(zhì)18

N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide

利格列汀雜質(zhì)19

(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

利格列汀雜質(zhì)20

(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide

利格列汀雜質(zhì)21

(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

利格列汀雜質(zhì)22

(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione

利格列汀雜質(zhì)23

(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

利格列汀雜質(zhì)24

(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質(zhì)25

(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

03/104-105

HTLV-90 (antibody) Monitor Sample

13/223

Influenza Antigen B/Massachusetts/02/2101 (Egg derived)

13/184

C-Peptide, Human. 39st International Standard.

10/111

Reteplase Reference Material

13/176

C-Peptide, Human. 31st International Standard.

13/264

Polio Anti Sabin type 47 (inactivated) Serum

13/239

Polio Anti Sabin type 22 (inactivated) Serum

13/265

Polio Anti Sabin type 48 (inactivated) Serum

95/659

Interleukin-120 (Human, rDNA derived)

13/189

Influenza Antigen B/Massachusetts/02/2067 (Egg derived)

01/447

Meningococcal serogroup W polysaccharide

13/151

C-Peptide, Human. 6st International Standard.

13/150

C-Peptide, Human. 5st International Standard.

10/134

Reteplase Reference Material

13/146

C-Peptide, Human. 1st International Standard.

95/616

Interleukin-77 (Human, rDNA derived)

07/359

BCG Vaccine of Russian BCG-I sub-strain(86st WHO Reference Reagent)

13/243

C-Peptide, Human. 98st International Standard.

07/290

BCG Vaccine of Russian BCG-I sub-strain(17st WHO Reference Reagent)

03/104-032

HTLV-17 (antibody) Monitor Sample

03/104-039

HTLV-24 (antibody) Monitor Sample

95/563

Interleukin-24 (Human, rDNA derived)

13/164

Influenza Antigen B/Massachusetts/02/2042 (Egg derived)

12/B623-068

QCRFLUAH1N1QC1-Influenza AH1N1 QC66

07/292

BCG Vaccine of Russian BCG-I sub-strain(19st WHO Reference Reagent)